Replies to post #199826 on Biotech Values

[DewDiligence]

…just saw a DTC ad for Pradaxa and one of the primary messages was that it's the only NOAC with an antidote.

The Pradaxa antidote, called Praxbind (#msg-117775017), is owned and marketed by the same company that markets Pradaxa (B-I), so it’s a rather different scenario than what’s in store for the oral FXa inhibitors.